About Clinic AC⁺
AC⁺ Medical Group is a leading cell therapy provider in the Kansai region. The group operates its own CPC in Osaka City and has built an integrated medical system covering medical services, cell culture, and cell therapy administration.
Drawing on accumulated experience and expertise, we collaborate with the Affiliated Hospital of Kyoto University Faculty of Medicine, the Affiliated Hospital of Osaka University Faculty of Medicine, and Kyoto Prefectural University of Medicine, striving to deliver high‑quality regenerative medicine.
Autologous Adipose‑Derived Stem Cell Therapy
Autologous adipose‑derived stem cell therapy is a regenerative treatment. Stem cells are harvested from the patient’s own body fat, cultured, and then administered back into the body.
Thanks to the reparative effects of stem cells, it is expected to regenerate damaged tissue and restore its function.
NK Cell Therapy
NK cells are a type of immune cell naturally present in the human body. These cells identify and eliminate abnormal cells such as cancer cells, bacteria, and viruses.
By boosting NK cell activity and quantity, this therapy aims to enhance immune function and the body’s defense capability.
Stem Cell Culture Supernatant Fluid
Stem cell culture supernatant is a culture fluid extracted and purified from beneficial substances secreted during the in‑vitro culture of mesenchymal stem cells. These stem cells are sourced from adipose tissue, umbilical cord, bone marrow, dental pulp, and amniotic membrane.
ACRS Therapy
ACRS is a therapeutic material derived from the patient’s own serum. It is obtained by collecting and processing the patient’s blood, which is rich in growth factors and cytokines.
It is used as a regenerative treatment to promote tissue and cell repair and activation, suppress inflammation, and improve the body’s natural healing capacity.
AC⁺ Japanese Smart Injection Pen | Full‑Body Rejuvenation at Cellular Level
ABOUT US
AC⁺ Medical Group is a Japan‑based regenerative medicine medical group. Working alongside leading academic medical institutions, the group brings together a seasoned panel of clinical and research experts. Operating an in‑house cell laboratory, it follows standardized workflows for cell processing and quality management under local regulatory requirements.